Article

Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods

Sutanaya Pal1★, Ekta Franscina Pinto2, Nitin B. Raut3, Girish Banwari4, Chittaranjan Andrade4★ Corresponding author

  1. 1Department of Psychiatry, Medical College Baroda, Vadodara, Gujarat, India.
  2. 2Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India.
  3. 3Department of Psychiatry, Dr. B R Ambedkar Central Railways Hospital, Byculla, Mumbai, Maharashtra, India.
  4. 4Neuron Psychological Care Center, Abu Dhabi, UAE.

CORRESPONDENCE

Sutanaya Pal

Department of Psychiatry, Medical College Baroda, Vadodara, Gujarat, India.

pal.sutanaya@gmail.com

Received: 07-01-2016; Accepted: 03-03-2016.

Volume 7, Issue 3 · pp. 152–152 · PUBLISHED 2016 · DOI: 10.4103/0976-500X.189688

View on JPP original site ↗

ABSTRACT

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Pal, S., Pinto, E. F., Raut, N. B., Banwari, G., & Andrade, C. (2016). Randomized controlled comparison of agomelatine and escitalopram: Concerns about study design and methods. Journal of Pharmacology and Pharmacotherapeutics, 7(3), 152–152. https://doi.org/10.4103/0976-500X.189688